{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T15:15:41Z","timestamp":1792163741597,"version":"4.4.0"},"reference-count":21,"publisher":"Wiley","issue":"12","license":[{"start":{"date-parts":[[2017,11,9]],"date-time":"2017-11-09T00:00:00Z","timestamp":1510185600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2017,11,9]],"date-time":"2017-11-09T00:00:00Z","timestamp":1510185600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Forest Research Institute, Inc., an Allergan affiliate"},{"DOI":"10.13039\/501100003358","name":"Gedeon Richter","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003358","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["wiley.com"],"crossmark-restriction":true},"short-container-title":["Int J Clin Pract"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1111\/ijcp.13037","type":"journal-article","created":{"date-parts":[[2017,11,9]],"date-time":"2017-11-09T08:42:44Z","timestamp":1510216964000},"page":"e13037","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Global improvement with cariprazine in the treatment of bipolar I disorder and schizophrenia: A pooled post hoc analysis"],"prefix":"10.1155","volume":"71","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6629-0619","authenticated-orcid":false,"given":"Suresh","family":"Durgam","sequence":"first","affiliation":[{"name":"Clinical Development; Allergan; Jersey City NJ USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willie","family":"Earley","sequence":"additional","affiliation":[{"name":"Clinical Development; Allergan; Jersey City NJ USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaifeng","family":"Lu","sequence":"additional","affiliation":[{"name":"Biostatistics; Allergan; Jersey City NJ USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gy\u00f6rgy","family":"N\u00e9meth","sequence":"additional","affiliation":[{"name":"Medical Division; Gedeon Richter Plc; Budapest Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Istv\u00e1n","family":"Laszlovszky","sequence":"additional","affiliation":[{"name":"Medical Division; Gedeon Richter Plc; Budapest Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Volk","sequence":"additional","affiliation":[{"name":"Medical Director; Apostle Clinical Trials; Long Beach CA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert E.","family":"Litman","sequence":"additional","affiliation":[{"name":"Medical Director; CBH Health LLC; Rockville MD USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2017,11,9]]},"reference":[{"key":"10.1111\/ijcp.13037-BIB0001|ijcp13037-cit-0001","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1192\/bjp.133.5.429","article-title":"A rating scale for mania: reliability, validity and sensitivity","volume":"133","author":"Young","year":"1978","journal-title":"Br J Psychiatry"},{"key":"10.1111\/ijcp.13037-BIB0002|ijcp13037-cit-0002","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr Bull"},{"key":"10.1111\/ijcp.13037-BIB0003|ijcp13037-cit-0003","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0895-4356(03)00044-1","article-title":"Defining clinically meaningful change in health-related quality of life","volume":"56","author":"Crosby","year":"2003","journal-title":"J Clin Epidemiol"},{"key":"10.1111\/ijcp.13037-BIB0004|ijcp13037-cit-0004","series-title":"Publication ADM 76-338","first-page":"217","volume-title":"ECDEU Assessment Manual for Psychopharmacology","author":"Guy","year":"1976"},{"key":"10.1111\/ijcp.13037-BIB0005|ijcp13037-cit-0005","first-page":"28","article-title":"The Clinical Global Impressions Scale: Applying a research tool in clinical practice","volume":"4","author":"Busner","year":"2007","journal-title":"Psychiatry (Edgmont)"},{"key":"10.1111\/ijcp.13037-BIB0006|ijcp13037-cit-0006","doi-asserted-by":"crossref","first-page":"284","DOI":"10.4088\/JCP.14m09081","article-title":"Efficacy and safety of low- and high-dose cariprazine in acute and mixed mania associated with bipolar I disorder: a double-blind, placebo-controlled study","volume":"76","author":"Calabrese","year":"2015","journal-title":"J Clin Psychiatry"},{"key":"10.1111\/ijcp.13037-BIB0007|ijcp13037-cit-0007","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/bdi.12238","article-title":"The efficacy and tolerability of cariprazine in acute mania associated with bipolar I disorder: a phase II trial","volume":"17","author":"Durgam","year":"2015","journal-title":"Bipolar Disord"},{"key":"10.1111\/ijcp.13037-BIB0008|ijcp13037-cit-0008","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.jad.2014.11.018","article-title":"Cariprazine in the treatment of acute mania in bipolar I disorder: a double-blind, placebo-controlled, phase III trial","volume":"174","author":"Sachs","year":"2015","journal-title":"J Affect Disord"},{"key":"10.1111\/ijcp.13037-BIB0009|ijcp13037-cit-0009","doi-asserted-by":"crossref","first-page":"e1574","DOI":"10.4088\/JCP.15m09997","article-title":"Cariprazine in acute exacerbation of schizophrenia: a fixed-dose, phase 3, randomized, double-blind, placebo- and active-controlled trial","volume":"76","author":"Durgam","year":"2015","journal-title":"J Clin Psychiatry"},{"key":"10.1111\/ijcp.13037-BIB0010|ijcp13037-cit-0010","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.schres.2013.11.041","article-title":"An evaluation of the safety and efficacy of cariprazine in patients with acute exacerbation of schizophrenia: a phase II, randomized clinical trial","volume":"152","author":"Durgam","year":"2014","journal-title":"Schizophr Res"},{"key":"10.1111\/ijcp.13037-BIB0011|ijcp13037-cit-0011","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1097\/JCP.0000000000000346","article-title":"Efficacy and safety of cariprazine in acute exacerbation of schizophrenia: results from an international, phase III clinical trial","volume":"35","author":"Kane","year":"2015","journal-title":"J Clin Psychopharmacol"},{"key":"10.1111\/ijcp.13037-BIB0012|ijcp13037-cit-0012","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/YIC.0000000000000110","article-title":"Cariprazine in the treatment of schizophrenia: a proof-of-concept trial","volume":"31","author":"Durgam","year":"2016","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1111\/ijcp.13037-BIB0013|ijcp13037-cit-0013","volume-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"2000","edition":"4"},{"key":"10.1111\/ijcp.13037-BIB0014|ijcp13037-cit-0014","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1399-5618.2009.00726.x","article-title":"The International Society for Bipolar Disorders (ISBD) Task Force report on the nomenclature of course and outcome in bipolar disorders","volume":"11","author":"Tohen","year":"2009","journal-title":"Bipolar Disord"},{"key":"10.1111\/ijcp.13037-BIB0015|ijcp13037-cit-0015","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1001\/archpsyc.65.4.386","article-title":"Residual symptom recovery from major affective episodes in bipolar disorders and rapid episode relapse\/recurrence","volume":"65","author":"Judd","year":"2008","journal-title":"Arch Gen Psychiatry"},{"key":"10.1111\/ijcp.13037-BIB0016|ijcp13037-cit-0016","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1176\/appi.ajp.162.3.441","article-title":"Remission in schizophrenia: proposed criteria and rationale for consensus","volume":"162","author":"Andreasen","year":"2005","journal-title":"Am J Psychiatry"},{"key":"10.1111\/ijcp.13037-BIB0017|ijcp13037-cit-0017","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12991-015-0042-6","article-title":"Clinical Global Impression-severity score as a reliable measure for routine evaluation of remission in schizophrenia and schizoaffective disorders","volume":"14","author":"Pinna","year":"2015","journal-title":"Ann Gen Psychiatry"},{"key":"10.1111\/ijcp.13037-BIB0018|ijcp13037-cit-0018","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1038\/sj.npp.1301147","article-title":"Linking the PANSS, BPRS, and CGI: clinical implications","volume":"31","author":"Leucht","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1111\/ijcp.13037-BIB0019|ijcp13037-cit-0019","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.jad.2017.09.040","article-title":"Clinically relevant response and remission outcomes in cariprazine-treated patients with bipolar I disorder","volume":"226","author":"Earley","year":"2018","journal-title":"J Affect Disord"},{"key":"10.1111\/ijcp.13037-BIB0020|ijcp13037-cit-0020","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1111\/j.1365-2753.2007.00921.x","article-title":"The validity of the CGI severity and improvement scales as measures of clinical effectiveness suitable for routine clinical use","volume":"14","author":"Berk","year":"2008","journal-title":"J Eval Clin Pract"},{"key":"10.1111\/ijcp.13037-BIB0021|ijcp13037-cit-0021","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0165-1781(97)00123-6","article-title":"Modification of the Clinical Global Impressions (CGI) Scale for use in bipolar illness (BP): the CGI-BP","volume":"73","author":"Spearing","year":"1997","journal-title":"Psychiatry Res"}],"container-title":["International Journal of Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fijcp.13037","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/ijcp.13037\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,6]],"date-time":"2022-08-06T22:03:49Z","timestamp":1659823429000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ijcp.13037"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,9]]},"references-count":21,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2017,12]]}},"URL":"https:\/\/doi.org\/10.1111\/ijcp.13037","archive":["Portico"],"relation":{},"ISSN":["1368-5031"],"issn-type":[{"value":"1368-5031","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11,9]]}}}